ARCHIVES

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

This article is from The Cancer Letter archive.

Vol. 31 No. 19 | May 13, 2005

Download PDF Visit The Full Archive

Related Articles

DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease

July 30, 1993

Patient Advocacy: Committee To Advise NCI On Formation Of Liaison Group

February 28, 1997

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003

Survival After Liver Transplant Called Excellent In Study

November 28, 2003

In Brief: Susan O’Brien to move to UC Irvine Health

November 14, 2014

Drug Development Committee Demands, Gets Greater Voice In Contract Awards, Review of Unsolicited Proposals, Suggests RFP For New Screening Systems

January 2, 1976